The New York Times has a piece today on misoprostol, the FDA-approved ulcer medication that is more often used as an underground abortion pill. Ann Friedman’s piece in MoJo a couple years ago about Cytotec, Pfizer’s misoprostol, explored the drug’s rise as a go-to abortifacent, particularly among low-income, immigrant, and Latina women. Cytotec, readily available by mail, allows women to bypass increasing abortion hurdles in their states, like parental notification and waiting periods, barriers that women in religious conservative families simply can’t face. And at $2 a pill they’re cheap, cheaper even than drugs from a health clinic.
The Times piece points to two new studies that suggest misoprostol’s use for a DIY abortion is on the rise. As Ann wrote back in 2006, this development shouldn’t come as a surprise given ever-tightening abortion restrictions. “Despite the legal and health risks, Cytotec will likely remain an attractive choice for many women—so long as it stays out of the spotlight.” Perhaps the Times’ story, and the new research studies, will mean a place in the spotlight’s not far behind.
